|
|||||||||||||||||||||||||||||||||||||||||||
|
|
Key: Meeting
Showing releases 126-150 out of 952. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>
Public Release: 11-Feb-2013
Unchecked antibiotic use in animals may affect global human health The increasing production and use of antibiotics, about half of which is used in animal production, is mirrored by the growing number of antibiotic resistance genes, or ARGs, effectively reducing antibiotics' ability to fend off diseases -- in animals and humans. Contact: Layne Cameron Public Release: 8-Feb-2013
Combining plasma screening methods better identifies diagnostic and therapeutic targets For the first time, scientists have combined genomic and proteomic analysis of blood plasma to enhance identification of genetically regulated protein traits. This could be applied to any large association study of civilization diseases such as diabetes, cardiovascular disease or cancer, where blood plasma has been collected. This method could vastly improve a clinician's ability to identify disease susceptibility in individuals and populations. Contact: Phyllis Edelman Public Release: 7-Feb-2013
Surveillance system can identify and track emerging infectious diseases A team of researchers developed a method to identify the cause of infectious disease outbreaks based on online reports about the symptoms, the season, and the ratio of cases to fatalities. Using data from the Internet outbreak reporting system ProMED-mail, the researchers applied this method to more than 100 outbreaks of encephalitis in South Asia, recently identified as an emerging infectious disease "hotspot," to determine which of 10 infectious diseases was causing symptoms of encephalitis Contact: Stephanie Berger Public Release: 7-Feb-2013
First anti-tuberculosis medicine under USAID-supported PQM program achieves WHO prequalification Helping to increase the availability of affordable, high-quality medicines to treat patients worldwide suffering from multi-drug resistant tuberculosis, technical assistance provided at no cost to manufacturers under the Promoting the Quality of Medicines program -- a U.S. Agency for International Development-funded program that is implemented by the U.S. Pharmacopeial Convention -- has yielded its first anti-tuberculosis medicine to achieve prequalification status from the World Health Organization. Contact: Francine Pierson Public Release: 7-Feb-2013
New study highlights Chagas disease as a growing health and socio-economic challenge Today, The Lancet Infectious Diseases published a new report that examines the global economic burden of Chagas disease. In the first study of its kind, researchers measured the health and economic impact of Chagas disease and found that the total economic burden of Chagas disease matches or exceeds that of many more well-known diseases such as rotavirus, Lyme disease and cervical cancer. Contact: Johanna Harvey Public Release: 6-Feb-2013
Has the 'Golden Age' of global health funding come to an end? Despite dire predictions in the wake of the economic crisis, donations to health projects in developing countries appear to be holding steady, according to the Institute for Health Metrics and Evaluation at the University of Washington. After reaching a historic high of $28.2 billion in 2010, development assistance for health dropped in 2011. Contact: Rhonda Stewart Public Release: 6-Feb-2013
Antibiotic cream has high cure rate, few side effects in treating cutaneous leishmaniasis An international collaboration of researchers from the US Army Medical Research and Materiel Command, Tunisia and France has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an investigational antibiotic cream. CL is a parasitic disease that causes disfiguring lesions, with 350 million people at risk worldwide and 1.5 million new cases annually. The results were published today in the New England Journal of Medicine. Contact: Carey Phillips Public Release: 5-Feb-2013
Human bacteria sequencing project involving CU raises $340,000 online In hopes of better understanding nutrition and health, the University of Colorado Boulder is playing the leading science role in a "crowdfunding" effort that has raised more than $340,000 for a project designed to sequence the gut bacteria of thousands of people around the world. Contact: Rob Knight Public Release: 5-Feb-2013
Scientists discover protein that allows safe recycling of iron from old red blood cells Scientists have long hypothesized that our bodies must have a special protein 'container' for transporting heme -- the form of iron found in living things -- during the breakdown and recycling of old red cells and other types of heme metabolism. Now a research team led by scientists from the University of Maryland have identified this long-sought heme-iron transporter and shown that it is the same HRG1 protein found in a common microscopic worm. Contact: Lee Tune Public Release: 4-Feb-2013
Injection-free vaccination technique could address global vaccine challenge for HIV, malaria Scientists at King's College London have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional needle, and shown for the first time that this technique is powerful enough to enable specialized immune cells in the skin to kick-start the immunizing properties of the vaccine. Contact: Katherine Barnes Public Release: 1-Feb-2013
Genetically modified tobacco plants produce antibodies to treat rabies Smoking tobacco is bad for your health, but a genetically altered version of the plant might provide an inexpensive cure for the deadly rabies virus. In a new report in The FASEB Journal, scientists produced a monoclonal antibody in transgenic tobacco plants shown to neutralize the rabies virus. This antibody works by preventing the virus from attaching to nerve endings around the bite site and keeping the virus from traveling to the brain. Contact: Cody Mooneyhan Public Release: 31-Jan-2013
UCSB anthropologists study effects of modernization on physical activity and heart disease Heart disease continues to be the leading cause of death in the United States, and a sedentary lifestyle is often cited as a major contributing factor. Among the Tsimane, an indigenous population in the lowlands of Bolivia's Amazon basin, however, indicators of heart disease are practically non-existent –– cholesterol is low, obesity is rare, and smoking is uncommon. Contact: Andrea Estrada Public Release: 31-Jan-2013
Placental blood flow can influence malaria during pregnancy Malaria in pregnancy causes a range of adverse effects, including abortions and stillbirths. In the latest issue of the journal PLOS Pathogen, researchers from the Instituto Gulbenkian de Ciência, Portugal, observed, for the first time, the mouse placental circulation and showed how it can influence the malaria parasite behavior and infection. Their results indicate a higher accumulation of parasites in placental regions with low blood flow, being these areas more prone to an inflammatory response. Contact: Ana Mena Public Release: 31-Jan-2013
African Programme for Onchocerciasis Control 1995-2015: Model-estimated health impact and cost A relatively inexpensive program set up to combat river blindness has resulted in major health improvements in Africa, shows a study conducted by Erasmus University Medical Center researchers. The study, due to be published Jan. 31 in PLOS Neglected Tropical Diseases, shows that US $250 million helped cure or prevent the major symptoms of onchocerciasis in millions of people. In collaboration with the Management of the African Programme for Onchocerciasis Control (APOC), the researchers calculated the health impact of APOC. Contact: Matthew Lopez Public Release: 30-Jan-2013
'Petri dish lens' gives hope for new eye treatments A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University. Contact: Emily Walker Public Release: 30-Jan-2013
UNC scientists unveil a superbug's secret to antibiotic resistance Many strains of the bacterium Staphyloccocus aureus are already resistant to all antibiotics except vancomycin. But as bacteria are becoming resistant to this once powerful antidote, S. aureus has moved one step closer to becoming an unstoppable killer. Now, researchers at the University of North Carolina at Chapel Hill have not only identified the mechanism by which vancomycin resistance spreads from one bacterium to the next, but have suggested ways to potentially stop the transfer. Contact: Thania Benios Public Release: 30-Jan-2013
New drug target identified for multiple sclerosis and Alzheimer's disease Researchers at Boston University School of Medicine report that the protein Klotho plays an important role in the health of myelin, the insulating material allowing for the rapid communication between nerve cells. These findings may lead to new therapies for multiple sclerosis and Alzheimer's disease, in which white matter abnormalities are also common but have been largely ignored. Contact: Gina DiGravio Public Release: 30-Jan-2013
Study finds parasites and poor antenatal care are main causes of epilepsy in Africa The largest study of epilepsy in sub-Saharan Africa to date reveals that programs to control parasitic diseases and access to better antenatal care could substantially reduce the prevalence of the disease in this region. Contact: Jen Middleton Public Release: 30-Jan-2013
Antibiotics cut death rate for malnourished children Severely malnourished children are far more likely to recover and survive when given antibiotics along with a therapeutic peanut-based food than children who are simply treated with the therapeutic food alone, researchers at Washington University School of Medicine in St. Louis have found. Contact: Elizabethe Holland Durando Public Release: 30-Jan-2013
Tenofovir gel wins out in drug absorption study, but HIV prevention trials say differently A study looking at how the body absorbs the antiretroviral drug tenofovir as either an oral tablet or a vaginal gel found the gel achieves much higher concentrations of active drug in vaginal tissue than the tablet, suggesting it to be highly effective in protecting against HIV through vaginal sex. But results of HIV prevention trials have shown differently, leading researchers to conclude that effectiveness of tenofovir products depends not just on tissue concentrations. Contact: Clare Collins Public Release: 30-Jan-2013
Forsyth scientists gain new understanding of latent tuberculosis Scientists at the Forsyth have gained new insight on how Tuberculosis (TB) remains a global epidemic. The Forsyth team, and its collaborators from Stanford University, has recently discovered that Mycobacterium tuberculosis, the bacteria that causes TB, can lay dormant and thrive within bone marrow stem cells. Contact: Jennifer Kelly Public Release: 29-Jan-2013
More research into chronic diseases urgently needed in all countries When considering chronic (non-communicable) diseases, such as cardiovascular disease and diabetes, in low-and-middle countries, a major shift in approach from declaring what needs to be done to using research to prioritize, evaluate, monitor and improve health outcomes is urgently needed, according to international experts from London School of Hygiene & Tropical Medicine writing in this week's PLOS Medicine. Contact: Sumrina Yousufzia Public Release: 28-Jan-2013
DRI to led efforts in clean water, sanitation and hygiene solutions in developing nations Dr. Braimah Apambire recently has been selected as the Senior Assistant to the President for Global Sustainability and Director for Water, Sanitation and Hygiene programs at the Desert Research Institute. This opportunity was made possible through a generous three year grant of $500,000 from the Conrad N. Hilton Foundation. It will support Apambire's work with DRI to create a center on Water, Development and Sustainability issues. Contact: Ashley Conroy Public Release: 28-Jan-2013
Pandemic controversies: The global response to pandemic influenza must change "Evil" scientists, deadly viruses and terrorist plots are usually the preserve of Hollywood blockbusters. But when it comes to pandemic influenza, it is the stuff of real life. As controversy about H5N1 bird flu virus research continues, a new paper argues for a new approach to pandemic preparedness. Contact: Julia Day Public Release: 24-Jan-2013
Stigma stymies prostate cancer screening, treatment in Ghana A new study published in January in the journal BMC Cancer, led by Kosj Yamoah, M.D., Ph.D., a resident in the Department of Radiation Oncology at Thomas Jefferson University and Hospital, takes aim at cancer disparities and stigma by investigating prostate cancer diagnoses and treatment delivery in black men living in the West African region, in order to devise research strategies to help improve health outcomes. Contact: Steve Graff
Showing releases 126-150 out of 952. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||